Literature DB >> 22703925

"On-target" cardiac effects of anticancer drugs: lessons from new biology.

Michael Simons, Anne Eichmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22703925      PMCID： PMC4049123          DOI： 10.1016/j.jacc.2012.01.069

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  12 in total

1.  The FGF system has a key role in regulating vascular integrity.

Authors:  Masahiro Murakami; Loc T Nguyen; Zhen W Zhuang; Zhen W Zhang; Karen L Moodie; Peter Carmeliet; Radu V Stan; Michael Simons
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

2.  Cardiovascular and systemic microvascular effects of anti-vascular endothelial growth factor therapy for cancer.

Authors:  J Todd Belcik; Yue Qi; Beat A Kaufmann; Aris Xie; Sherry Bullens; Terry K Morgan; Susan P Bagby; Ganesh Kolumam; Joe Kowalski; Jon A Oyer; Stuart Bunting; Jonathan R Lindner
Journal:  J Am Coll Cardiol       Date:  2012-06-13       Impact factor: 24.094

3.  Autocrine VEGF signaling is required for vascular homeostasis.

Authors:  Sunyoung Lee; Tom T Chen; Chad L Barber; Maria C Jordan; Jared Murdock; Sharina Desai; Napoleone Ferrara; Andras Nagy; Kenneth P Roos; M Luisa Iruela-Arispe
Journal:  Cell       Date:  2007-08-24       Impact factor: 41.582

4.  Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure.

Authors:  Ichiro Shiojima; Kaori Sato; Yasuhiro Izumiya; Stephan Schiekofer; Masahiro Ito; Ronglih Liao; Wilson S Colucci; Kenneth Walsh
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

5.  Circulating angiogenic factors and the risk of preeclampsia.

Authors:  Richard J Levine; Sharon E Maynard; Cong Qian; Kee-Hak Lim; Lucinda J England; Kai F Yu; Enrique F Schisterman; Ravi Thadhani; Benjamin P Sachs; Franklin H Epstein; Baha M Sibai; Vikas P Sukhatme; S Ananth Karumanchi
Journal:  N Engl J Med       Date:  2004-02-05       Impact factor: 91.245

Review 6.  VEGF as a potential target for therapeutic intervention in depression.

Authors:  Jennifer L Warner-Schmidt; Ronald S Duman
Journal:  Curr Opin Pharmacol       Date:  2007-12-03       Impact factor: 5.547

7.  VEGF inhibition and renal thrombotic microangiopathy.

Authors:  Vera Eremina; J Ashley Jefferson; Jolanta Kowalewska; Howard Hochster; Mark Haas; Joseph Weisstuch; Catherine Richardson; Jeffrey B Kopp; M Golam Kabir; Peter H Backx; Hans-Peter Gerber; Napoleone Ferrara; Laura Barisoni; Charles E Alpers; Susan E Quaggin
Journal:  N Engl J Med       Date:  2008-03-13       Impact factor: 91.245

8.  Myocardial hypertrophy in the absence of external stimuli is induced by angiogenesis in mice.

Authors:  Daniela Tirziu; Emmanuel Chorianopoulos; Karen L Moodie; Robert T Palac; Zhen W Zhuang; Marc Tjwa; Carmen Roncal; Ulf Eriksson; Qiangwei Fu; Arye Elfenbein; Amy E Hall; Peter Carmeliet; Lieve Moons; Michael Simons
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

9.  Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele.

Authors:  P Carmeliet; V Ferreira; G Breier; S Pollefeyt; L Kieckens; M Gertsenstein; M Fahrig; A Vandenhoeck; K Harpal; C Eberhardt; C Declercq; J Pawling; L Moons; D Collen; W Risau; A Nagy
Journal:  Nature       Date:  1996-04-04       Impact factor: 49.962

10.  Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene.

Authors:  N Ferrara; K Carver-Moore; H Chen; M Dowd; L Lu; K S O'Shea; L Powell-Braxton; K J Hillan; M W Moore
Journal:  Nature       Date:  1996-04-04       Impact factor: 49.962
View more
  8 in total

Review 1.  Modulation of VEGF receptor 2 signaling by protein phosphatases.

Authors:  Federico Corti; Michael Simons
Journal:  Pharmacol Res       Date:  2016-11-23       Impact factor: 7.658

2.  Cardiovascular assessment after treatment for retinopathy of prematurity: a comparative study between anti-VEGF agent (aflibercept) and laser.

Authors:  Erman Cilsal; Emine Alyamac Sukgen
Journal:  Cardiovasc J Afr       Date:  2020-01-13       Impact factor: 1.167

3.  Inhibition of pathological brain angiogenesis through systemic delivery of AAV vector expressing soluble FLT1.

Authors:  F Shen; L Mao; W Zhu; M T Lawton; P Pechan; P Colosi; Z Wu; A Scaria; H Su
Journal:  Gene Ther       Date:  2015-06-19       Impact factor: 5.250

4.  Drug-Related Hypertension Associated with the Efficacy of Apatinib on Hepatocellular Carcinoma.

Authors:  XueJiao Yang; ZhenYu Hou; KeYun Zhu; Su Zhang; XiaoYing Gu; ZhiWei Wang; Han Mu; HongYuan Zhou; Ping Chen; XiaoLin Zhu; YunLong Cui; Qiang Li; HuiKai Li; Ti Zhang
Journal:  Cancer Manag Res       Date:  2020-05-06       Impact factor: 3.989

5.  The neuropilin 1 cytoplasmic domain is required for VEGF-A-dependent arteriogenesis.

Authors:  Anthony Lanahan; Xi Zhang; Alessandro Fantin; Zhen Zhuang; Felix Rivera-Molina; Katherine Speichinger; Claudia Prahst; Jiasheng Zhang; Yingdi Wang; George Davis; Derek Toomre; Christiana Ruhrberg; Michael Simons
Journal:  Dev Cell       Date:  2013-04-29       Impact factor: 12.270

Review 6.  Hypertension in malignancy-an underappreciated problem.

Authors:  Jolanta Małyszko; Maciej Małyszko; Leszek Kozlowski; Klaudia Kozlowska; Jacek Małyszko
Journal:  Oncotarget       Date:  2018-04-17

Review 7.  Hypertension management in cardio-oncology.

Authors:  Hani Essa; Rebecca Dobson; David Wright; Gregory Y H Lip
Journal:  J Hum Hypertens       Date:  2020-08-03       Impact factor: 3.012

8.  Regulation of VEGFR2 trafficking and signaling by Rab GTPase-activating proteins.

Authors:  Ye Xie; Maysam Mansouri; Aurélien Rizk; Philipp Berger
Journal:  Sci Rep       Date:  2019-09-16       Impact factor: 4.379
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.